Laboratory Findings on Admission
Compared with non-critical patients, the inflammatory biomarkers in critical patients including c-reactive protein (CRP), procalcitonin (PCT), interleukin-2 receptor (IL-2R), α-tumor necrosis factor (TNF-A) and Interleukin-6 (IL-6) were significantly higher (p <0.05). The cardiac biomarkers in critical patients including creatine kinase MB (CK-MB), high-sensitivity troponin I (hs-cTnI), creatine kinase (CK), lactate dehydrogenase (LDH), α - hydroxybutyrate dehydrogenase (HBDH) and brain natriuretic peptide (BNP) were significantly higher than non-critical patients (p <0.001). There were numerous differences in other baseline laboratory findings between two groups, including longer prothrombin time, higher levels of D-dimer and aspartate aminotransferase (AST) (Table 3).